Reviewing Global Medical REIT (GMRE) & Its Rivals

Global Medical REIT (NYSE: GMRE) is one of 23 public companies in the “Healthcare REITs” industry, but how does it contrast to its peers? We will compare Global Medical REIT to related companies based on the strength of its profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and earnings.

Volatility and Risk

Global Medical REIT has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Global Medical REIT’s peers have a beta of 0.36, indicating that their average share price is 64% less volatile than the S&P 500.

Institutional & Insider Ownership

41.0% of Global Medical REIT shares are held by institutional investors. Comparatively, 82.7% of shares of all “Healthcare REITs” companies are held by institutional investors. 16.5% of Global Medical REIT shares are held by company insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for Global Medical REIT and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT 0 1 5 0 2.83
Global Medical REIT Competitors 144 760 683 12 2.35

Global Medical REIT presently has a consensus target price of $10.75, suggesting a potential upside of 28.59%. As a group, “Healthcare REITs” companies have a potential upside of 9.02%. Given Global Medical REIT’s stronger consensus rating and higher possible upside, analysts plainly believe Global Medical REIT is more favorable than its peers.

Valuation & Earnings

This table compares Global Medical REIT and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Global Medical REIT $8.21 million -$6.35 million -30.96
Global Medical REIT Competitors $812.10 million $208.81 million 176.36

Global Medical REIT’s peers have higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Dividends

Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.6%. Global Medical REIT pays out -296.3% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.6% and pay out 133.6% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.

Profitability

This table compares Global Medical REIT and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Global Medical REIT -19.98% -2.86% -1.39%
Global Medical REIT Competitors 35.60% 7.69% 3.77%

Summary

Global Medical REIT peers beat Global Medical REIT on 9 of the 15 factors compared.

About Global Medical REIT

Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit